Phacoemulsification Devices Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Phacoemulsification Devices Market: By Product Type (Devices, Accessories) By Technology (Manually Operated Inhalers, Digitally Operated Inhalers), By Distribution Channel (Hospitals, Ophthalmic Clinics, Others), and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Global phacoemulsification devices market is projected to reach USD 374 Mn by 2027 growing at a CAGR of 4.3% during the forecast period 2021 to 2027. Phacoemulsification is a cataract surgical procedure in which the internal lens of the eye is emulsified. The procedure is carried out by performing incisions in the eye to allow the surgical instruments. Two small incisions are made in the eye where the clear front covering of the eye (Cornea) meets the sclera. A circular opening is made in the front part of lens capsule. A surgical instrument (phaco probe) is inserted into the eye. The lens is broken and is removed, the surgeon uses suction in order to remove the pieces of the lens. The popularity of the phacoemulsification technology has risen dramatically as a result of technological improvements that have increased its efficiency and safety. The success of this method is due to the development of viscoelastic agents combined with contemporary phacoemulsification processes. The incidence of both postoperative and intraoperative capsular problems has decreased as a result of improved surgical procedures for removing anterior lens capsules. Furthermore, nucleus removal is now performed in the posterior chamber rather than the anterior chamber, resulting in less injury to the corneal endothelium. During the projected period, the phacoemulsification devices market is expected to grow at a significant rate. The benefits associated with phacoemulsification devices, including as smaller incisions, quick recovery, no need for hospitalisation, fewer intraoperative and postoperative problems, and early visual rehabilitation, have contributed to the market’s rise. Furthermore, the high popularity of the phacoemulsification procedure for the surgical removal of cataracts is due to no restrictions on regular activities and less caused astigmatism due to a smaller incision.

Phacoemulsification Devices Market

MARKET SUMMARY
-
4.3% CAGR
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR– 4.3%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Phacoemulsification Devices Market

  • The report on global Phacoemulsification Devices Market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, technology, distribution channel and geography.
  • Phacoemulsification Devices Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Johnson & Johnson Vision (U.S)
  • Zeiss (Germany)
  • NIDEK (Japan)
  • Alcon (U.S)
  • Baush + Lomb (U.S)
Dynamics

Phacoemulsification Devices Market

Increase in prevalence of eye diseases and growing geriatric population with refractive errors are anticipated to drive the phacoemulsification devices market. The increased awareness about advanced surgical procedures, adoption of the modern surgical treatments, support from the government and the non-profitable organizations are expected to drive the growth of phacoemulsification devices market. The improving healthcare infrastructure, adoption of new treatment methods are expected to offers for market players. However, the high cost of the device, poor reimbursement policies and stringent government regulations are expected to hamper the growth of phacoemulsification devices market.


North-America got significant share

Phacoemulsification Devices Market

Geographically, global phacoemulsification devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America phacoemulsification devices market is expected to dominate the global market, followed by Europe and Asia Pacific. North Americaphacoemulsification devices market is expanding at healthy growth rate due to increase in prevalence of eye diseases. The affordability of the treatment, increased public and private healthcare insurance is expected to enhance the growth of the market. The Europe phacoemulsification devices market is projected to grow at modest rates owing to economic slowdown. The Asia Pacific phacoemulsification devices market is expected to offer enormous opportunities due increasing healthcare infrastructure in emerging countries such as India, China and South Korea.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0

Phacoemulsification Devices Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Johnson & Johnson Vision (U.S)
  • Zeiss (Germany)
  • NIDEK (Japan)
  • Alcon (U.S)
  • Baush + Lomb (U.S)
  • Optikon (Italy)
  • MEDA Co. LTD (China)
  • Topcon (Japan)

Description

Global phacoemulsification devices market is projected to reach USD 374 Mn by 2027 growing at a CAGR of 4.3% during the forecast period 2021 to 2027. Phacoemulsification is a cataract surgical procedure in which the internal lens of the eye is emulsified. The procedure is carried out by performing incisions in the eye to allow the surgical instruments. Two small incisions are made in the eye where the clear front covering of the eye (Cornea) meets the sclera. A circular opening is made in the front part of lens capsule. A surgical instrument (phaco probe) is inserted into the eye. The lens is broken and is removed, the surgeon uses suction in order to remove the pieces of the lens. The popularity of the phacoemulsification technology has risen dramatically as a result of technological improvements that have increased its efficiency and safety. The success of this method is due to the development of viscoelastic agents combined with contemporary phacoemulsification processes. The incidence of both postoperative and intraoperative capsular problems has decreased as a result of improved surgical procedures for removing anterior lens capsules. Furthermore, nucleus removal is now performed in the posterior chamber rather than the anterior chamber, resulting in less injury to the corneal endothelium. During the projected period, the phacoemulsification devices market is expected to grow at a significant rate. The benefits associated with phacoemulsification devices, including as smaller incisions, quick recovery, no need for hospitalisation, fewer intraoperative and postoperative problems, and early visual rehabilitation, have contributed to the market’s rise. Furthermore, the high popularity of the phacoemulsification procedure for the surgical removal of cataracts is due to no restrictions on regular activities and less caused astigmatism due to a smaller incision.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX